Lombard Medical Inc (EVAR)

0.05
0.00 (0.00)
OTC : Health Care
Prev Close 0.05
Open 0.05
Day Low/High 0.05 / 0.05
52 Wk Low/High 0.02 / 0.75
Volume 1.43K
Avg Volume 79.70K
Exchange OTC
Shares Outstanding 27.95M
Market Cap 6.15M
EPS -1.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Lombard Medical Reports 2015 Second Quarter, Six-Month Results

Lombard Medical Reports 2015 Second Quarter, Six-Month Results

Revenue Up 107 Percent Year-Over-Year; U.S. Sales Increase 123 Percent

First Clinical Cases Performed Using Lombard Medical's Aorfix(TM) Plus Endovascular Stent Graft

First Clinical Cases Performed Using Lombard Medical's Aorfix(TM) Plus Endovascular Stent Graft

Increased Diameter May Allow 10 Percent Increase in Aorfix-Treatable AAA Cases

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DENN, HCAP, ICCC, MITK, UBNT Downgrades: ARDM, ENLK, LB, MRCC, RICK, SMI, SRT Initiations: EVAR, VUZI, ZOES Read on to get TheStreet Quant Ratings' detailed report:

First Commercial Cases With Lombard Medical's AorFlex(TM) Delivery System For Endovascular Aneurysm Repair Performed In Japan

First Commercial Cases With Lombard Medical's AorFlex(TM) Delivery System For Endovascular Aneurysm Repair Performed In Japan

AorFlex Delivery System Launched in Second Largest Standalone Endovascular Aneurysm Repair Market Through Exclusive Distribution Partner

Lombard Medical Reports 2015 First Quarter Results

Lombard Medical Reports 2015 First Quarter Results

Revenue Up 66 Percent Year-Over-Year; U.S. Sales Increase 125 Percent

Lombard Medical Reports 2014 Fourth Quarter, Full Year Financial Results

Lombard Medical Reports 2014 Fourth Quarter, Full Year Financial Results

Full Year Aorfix(TM) Revenue More Than Doubled Over 2013

Lombard Medical Initiates ARCHYTAS Global Clinical Registry

Lombard Medical Initiates ARCHYTAS Global Clinical Registry

Will Evaluate Clinical Outcomes of EVAR With Aorfix(TM) in Broad Cross-Section of AAA Patients

Lombard Medical Announces Preliminary 2014 Fourth Quarter And Full Year Revenues

Lombard Medical Announces Preliminary 2014 Fourth Quarter And Full Year Revenues

2014 Global Aorfix(TM) Revenue More than Doubled Year-over-Year

Lombard Medical Presents Two-Year Follow-Up Data From Aorfix(TM) PYTHAGORAS Pivotal Trial At 41st Annual VEITHsymposium

Lombard Medical Presents Two-Year Follow-Up Data From Aorfix(TM) PYTHAGORAS Pivotal Trial At 41st Annual VEITHsymposium

Positive Outcomes in Abdominal Aortic Aneurysm Patients With Challenging Anatomies Reinforce Clinical Value of Aorfix